Search

everythinglearnresearchcommunity

for

Search:↓

Hormonal imbalances during menopause may significantly contribute to Frontal Fibrosing Alopecia.

New microneedles deliver drugs through the skin accurately and effectively.

Changes in gut bacteria can contribute to the development of Polycystic Ovary Syndrome (PCOS), affecting metabolism, immunity, and causing inflammation. Treatments may involve adjusting these factors.

Understanding Polycystic Ovary Syndrome (PCOS) and its causes can lead to effective treatments.

Dermatologists are essential in helping transgender and gender diverse patients with skin and hair issues related to gender affirmation and hormone therapy.

Decursin shows promise for treating cancer, neuroprotection, inflammation, and hair loss.

Certain medications, including some immune drugs, contraceptives, and hair loss treatments, are often linked to hair loss.

Minoxidil patches and cold plasma may help treat hair loss.

Polymeric microneedles offer a less invasive, long-lasting drug delivery method that improves patient compliance and reduces side effects.

Some medications might contribute to male infertility, with finasteride showing a high number of reports.

Surgery can be a safe and effective option for infertile women with PCOS who don't respond to medication and want to get pregnant.

There are many ways to treat Polycystic Ovary Syndrome, including lifestyle changes, surgery, and various medications, but more research is needed for better treatments.

The follicular unit extraction method for hair transplants is a technique with benefits and drawbacks.

The document concludes that proper diagnosis and FDA-approved treatments for different types of hair loss exist, but treatments for severe cases often fail and future improvements may focus on hair follicle stem cells.

Cooling the scalp may prevent hair loss from chemotherapy, hair often grows back after treatment, and nail issues usually improve after stopping the drug.

Higher doses of oestradiol implants improve bone density in postmenopausal women.

The document concludes that androgenetic alopecia is common, has a genetic link, and can be diagnosed and treated with medications like finasteride and minoxidil.

Polycystic Ovary Syndrome (PCOS) can lead to diabetes, heart disease, cancer, and mental health problems.

The conclusion is that early diagnosis and a multi-system treatment approach are crucial for managing PCOS and its associated health risks.

Idiopathic hirsutism causes excessive hair growth in women, can be treated with medication and hair removal, but cannot be fully reversed.

Acne is linked to inflammation and insulin resistance, and is associated with various syndromes that require different treatments.

Minoxidil and finasteride are the main FDA-approved treatments for hair loss, with other methods showing promise but lacking strong evidence.

The spiny mouse is a unique menstruating rodent that can help us understand menstruation and reproductive disorders.

PCOS is a common hormonal disorder in women that can lead to various health issues and requires comprehensive management.

G-CSF effectively treated a teenager's cyclic neutropenia and reduced her symptoms without adverse effects.

The document concludes that managing health issues like menopause, cardiovascular risk, and hair loss is crucial for promoting longevity in aging women.

Some drugs can cause hair loss, excessive growth, or color changes, often reversible but sometimes permanent.

A new method can almost perfectly distinguish adenomyosis from similar conditions using blood tests.

Low testosterone in men is a risk factor for a specific heart rhythm issue, and testosterone treatment may help prevent it.

Testosterone therapy may improve mood, well-being, and sexual function in premenopausal women, but more research is needed on its long-term safety and effectiveness.